Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1888-1890

  Wu, Hsiu Mei ^a   Janapatla, Rajendra Prasad ^a   Ho, Yueh Ren ^a   Hung, Kuei Hsiang ^a   Wu, Chi Wen ^a   Yan, Jing Jou ^a   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GARENOXACIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CROSS RESISTANCE; GENE MUTATION; GYRA GENE; NONHUMAN; PARC GENE; PARE GENE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; TAIWAN;

BACTERIAL PROTEINS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; OFLOXACIN; STREPTOCOCCUS AGALACTIAE; TAIWAN;

EID: 42949107446     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00035-08     Document Type: Article

References (15)

1. Biedenbach, D. J., M. A. Toleman, T. R. Walsh, and R. N. Jones. 2006. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis. 55:119-127.
2. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th cd. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
4. González, I., M. Georgiou, F. Alcaide, D. Balas, J. Liñares, and A. G. de la Campa. 1998. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci. Antimicrob. Agents Chemother. 42:2792-2798.
5. Hooper, D. C. 2002. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis. 2:530-538.
6. Infectious Diseases Society of the Republic of China. 1999. Guidelines for antimicrobial therapy of pneumonia in Taiwan. J. Microbiol. Immunol. Infect. 32:292-294.
7. Jacoby, G. A. 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41:120-126.
8. Kawamura, Y., H. Fujiwara, N. Mishima, Y. Tanaka, A. Tanimoto, S. Ikawa, Y. Itoh, and T. Ezaki. 2003. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Chemother. 47:3605-3609.
9. Kawamura-Sato, K., T. Hasegawa, K. Torii, H. Ito, and M. Ohta. 2005. Prevalence of Ile-460-Val/ParE substitution in clinical Streptococcus pneumoniae isolates that were less susceptible to fluoroquinolones. Curr. Microbiol. 51:27-30.
10. Kays, M. B., G. G. Zhanel, M. A. Reimann, J. Jacohi, G. A. Denys, D. W. Smith, and M. F. Wack. 2007. Selection of a gyrA mutation and treatment failure with gatifloxacin in a patient with Streptococcus pneumoniae with a preexisting parC mutation. Pharmacotherapy 27:221-226.
11. Malhotra-Kumar, S., C. Lammens, S. Chapelle, C. Mallentjer, J. Weyler, and H. Goossens. 2005. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J. Antimicrob. Chemother. 55:320-325.
12. Mirò, E., M. Rebollo, A. Rivera, M. T. Alvarez, F. Navarro, B. Mirelis, and P. Coll. 2006. Streptococcus agalactiae highly resistant to fluoroquinolones. Enferm. Infecc. Microbiol. Clin. 24:562-563.
13. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
14. Wehbeh, W., R. Rojas-Diaz, X. Li, N. Mariano, L. Grenner, S. Segal-Maurer, B. Tommasulo, K. Drlica, C. Urban, and J. J. Rahal. 2005. Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob. Agents Chemother. 49:2495-2497.
15. Yan, S. S., M. L. Fox, S. M. Holland, F. Stock, V. J. Gill, and D. P. Fedorko. 2000. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob. Agents Chemother. 44:3196-3198.